Based on recent data, Bristol-Myers Squibb Company (BMY) shows an Average True Range (ATR) of 1.4 and an Enterprise Value of 129.03B. Its average trading volume over the past 3 months is 13.97M, indicating liquidity. These fundamental metrics provide insight into BMY's underlying financial health and market activity.
| ATR | 1.4 |
| Enterprise Value | 129.03B |
| Avg Vol (3 Months) | 13.97M |
| Avg Vol (10 Days) | 16.34M |
Bristol-Myers Squibb Company (BMY) technical indicators as of February 7, 2026: the SMA 20 is 10.71%, SMA 50 at 14.77%, and SMA 200 at 27.68%. The RSI 14 value is 77.61, suggesting its current momentum. These technical analysis signals help assess BMY's price trends and potential future movements.
| SMA 20 | 10.71% |
| SMA 50 | 14.77% |
| SMA 200 | 27.68% |
| RSI 14 | 77.61 |
Bristol-Myers Squibb Company (BMY) stock performance overview as of February 7, 2026: The 52-week high is $63.33 (currently -2.12% below), and the 52-week low is $42.52 (currently 45.79% above). Over the past year, BMY's performance is -3.83%, compared to the S&P 500's 8.57% change.
| 52-Week High | 63.33 |
| 52-Week High Chg | -2.12% |
| 52-Week Low | 42.52 |
| 52-Week Low Chg | +45.79% |
| S&P 500 52-Week Chg | 8.57% |
According to market data, Bristol-Myers Squibb Company (BMY) stock's recent performance metrics show that over the last month, BMY is 1.25%, with a Year-to-Date (YTD) performance of 0.52%. Over the past year, the stock has seen a -3.83% change. These figures summarize BMY's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 62.05 | 62.05 | 62.05 | 62.05 | 63.33 | 62.05 |
| Low | 54.96 | 53.55 | 45.27 | 42.52 | 42.52 | 52.06 |
| Performance | -2.78% | +1.25% | +24.27% | +16.13% | -3.83% | +0.52% |
According to current financial data, BMY stock's P/E (TTM) ratio is 17.86, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for BMY, including P/S (2.61), P/B (2.26), and P/FCF (8.23), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | BMY | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 17.86 | -1.23 | 69.86 | 32.59 |
| P/S (TTM) | 2.61 | 3.71 | 4.68 | 5.98 |
| P/B (TTM) | 2.26 | 0.95 | -0.4 | 5.47 |
| P/FCF (TTM) | 8.23 | -5.9 | 18.4 | 32.07 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep